1. Åberg, M., Nilsson, I. M., and Vilhardt, H., 1979, the release of fibrinolytic activator and factor VIII after injection of DDAVP, in: Progress in chemical fibrinolysis and thrombolysis, J. F. Davidson, ed., Churchill Livingstone, London and New York.
2. Aronson, A. S., Andersson, K. E., Bergstrand, C. G., and Mulder, J. L., 1973, Treatment of diabetes insipidus in children with DDAVP, a synthetic analogue of vasopressin, Acta Pædiat. Scand. 62: 133.
3. Aronson, A. S., and Svenningsen, N. W., 1974, DDAVP test for estimation of renal concentrating capacity in infants and children, Arch. Disease in Childhood 49: 654.
4. Aunsholt, N. A., Vilhardt, H., and Schmidt, E. B., 1986, Plasma half-life of DDAVP in uraemic patients, Acta Pharmacol. Toxicol. 59: 332.
5. Becker, D. J., and Foley, T. P., 1981, The effect of water deprivation and water loading during treatment with 1-deamino-8-D-arginine vasopressin in central diabetes insipidus in children, Acta Endocrinol. 97: 538.